Corteva (CTVA) Q3 2025 10-Q Quarterly Report
Corteva (CTVA) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Corteva Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue and YoY change not disclosed explicitly in provided text
- • Operating cash flow improved to $(941) million for 9 months ended Sept 30, 2025 vs $(1,871) million for same period in 2024
- • Cash, cash equivalents, and marketable securities $2.6B at Sept 30, 2025 vs $2.5B at Sept 30, 2024; total debt decreased to $4.4B from $5.7B YoY
- • Share repurchases $270M in Q3 2025 and $500M YTD 2025 under 2024 and 2022 buyback plans; dividend increased 5.9% to $0.18 per share in Q3 2025
- • Management highlights adequate liquidity, compliance with debt covenants and access to $6.3B credit lines; expects ~$ $1B total share repurchases in 2025
Risk Factors
- • New regulatory risk from recent funding and staff cuts at EPA, USDA, FDA, HHS plus current federal government shutdown impacting timely approvals
- • Updated material regulatory risk: reliance on Coordinated Framework for Biotechnology involving USDA, FDA, EPA authorities for seeds and pesticides
- • Operational risk: potential delay in regulatory approvals directly affecting product launch timelines and market access
- • Financial risk: no material liquidity or debt maturity changes disclosed compared to 2024 Annual Report
- • Competitive risk carried forward: dependence on regulatory clearances for genetically modified seeds and pesticidal products to maintain market position
Corteva Q3 2025 Quarterly FinancialsXBRL
Revenue
$2.6B
▲ +12.6% YoY▼ -59.4% QoQ
Net Income
-$320M
▲ +38.9% YoY▼ -124.4% QoQ
Net Margin
-12.2%
▲ +1030bp YoY▼ -3258bp QoQ
ROE
-1.3%
Total Assets
$42.2B
EPS (Diluted)
$-0.46
▲ +38.7% YoY▼ -124.0% QoQ
Operating Cash Flow
$193M
▲ +48.5% YoY▼ -79.6% QoQ
Source: XBRL data from Corteva Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Corteva Quarterly Reports
Get deeper insights on Corteva
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.